Skip to content

Clinical efficacy evaluation and mechanism study of acupuncture intervention in cerebral infraction

Clinical efficacy evaluation and mechanism study of acupuncture intervention in cerebral infraction

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300079204
Enrollment
Unknown
Registered
2023-12-27
Start date
2024-01-01
Completion date
Unknown
Last updated
2024-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cerebral infraction

Interventions

Experimental group :Acupuncture treatment and basic treatment

Sponsors

First Teaching Hospital of Tianjin University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 75 Years

Inclusion criteria

Inclusion criteria: (1) Individuals who satisfy the established diagnostic criteria for the ailment may be considered for inclusion in the therapeutic intervention, (2) initial manifestation of the ailment, (3) progression of the ailment within a time frame of 72 hours, (4) age range of 40 to 75 years, with no restrictions based on gender, (5) an NIHSS score ranging from 5 to less than 15, (6) willingness to participate voluntarily and provision of a duly signed informed consent.

Exclusion criteria

Exclusion criteria: (1) Individuals failing to meet the established inclusion criteria, (2) impairment of the Vesta channel's functionality resulting from craniocerebral trauma, tumors, and other etiologies, (3) assessment of the impact of acupuncture treatment or other therapeutic medications administered within a 3-month period prior to admission, (4) presence of consciousness disorders, deafness, severe depression, schizophrenia, and inability to cooperate, (5) coexistence of severe primary diseases affecting the cardiovascular, neurological, respiratory, hepatic, and renal systems, (6) severe dermatological conditions or hypersensitivity to the investigational treatment, (7) pregnant, lactating, or expecting women, (8) patients concurrently participating in other research studies.

Design outcomes

Primary

MeasureTime frame
National Institute of Health stroke scale ;

Secondary

MeasureTime frame
Simplified Fugl-Meyer assessment scale ;Barthel index ;Modified Rankin Scale ;

Countries

China

Contacts

Public ContactDu Yuanhao

First Teaching Hospital of Tianjin University of Traditional Chinese Medicine

jpjs_cn@sina.com+86 138 2182 0885

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 6, 2026